相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structural and Functional Changes of Reconstituted High-Density Lipoprotein (HDL) by Incorporation of α-synuclein: A Potent Antioxidant and Anti-Glycation Activity of α-synuclein and apoA-I in HDL at High Molar Ratio of α-synuclein
Kyung-Hyun Cho
MOLECULES (2021)
Elevated serum TC and LDL-C levels in Alzheimer's disease and mild cognitive impairment: A meta-analysis study
Yang Liu et al.
BRAIN RESEARCH (2020)
High density lipoprotein and its apolipoprotein-defined subspecies and risk of dementia
Manja Koch et al.
JOURNAL OF LIPID RESEARCH (2020)
Correlations between blood lipid, serum cystatin C, and homocysteine levels in patients with Parkinson's disease
Jia Li et al.
PSYCHOGERIATRICS (2020)
A systematic review and meta-analysis of serum cholesterol and triglyceride levels in patients with Parkinson's disease
Xiaoxue Fu et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Proteomics as a reliable approach for discovery of blood-based Alzheimer's disease biomarkers: A systematic review and meta-analysis
Siti Hajar Rehiman et al.
AGEING RESEARCH REVIEWS (2020)
Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson's Disease
Irina Alecu et al.
FRONTIERS IN NEUROSCIENCE (2019)
Association between carotid plaque and Parkinson's disease
Lan-Yun Yan et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Serum uric acid level and its association with motor subtypes and non-motor symptoms in early Parkinson's disease: PALS study
Xinxin Huang et al.
PARKINSONISM & RELATED DISORDERS (2018)
Higher serum triglyceride levels are associated with Parkinson's disease mild cognitive impairment
Xinxin Huang et al.
MOVEMENT DISORDERS (2018)
Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease
Per Johansson et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease
Yuki Kitamura et al.
NEUROLOGICAL RESEARCH (2017)
Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype
Christine R. Swanson et al.
MOVEMENT DISORDERS (2015)
Dynamic changes of Apo A1 mediated by LXR/RXR/ABCA1 pathway in brains of the aging rats with cerebral hypoperfusion
Linhui Wang et al.
BRAIN RESEARCH BULLETIN (2014)
Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: A pilot-study
Josef Marksteiner et al.
EXPERIMENTAL GERONTOLOGY (2014)
Plasma protein profiling of Mild Cognitive Impairment and Alzheimer's disease using iTRAQ quantitative proteomics
Fei Song et al.
PROTEOME SCIENCE (2014)
Plasma Apolipoprotein A1 as a Biomarker for Parkinson Disease
Judy K. Qiang et al.
ANNALS OF NEUROLOGY (2013)
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
Irene Litvan et al.
MOVEMENT DISORDERS (2012)
Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease
Terry L. Lewis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
分享论文
